The latest information

Antleron & Novasign digital twin approach for scalable cell & gene therapy bioprocess development showcased at ESACT 2024

Britt Van Ballaer develops bioreactor systems in support of scalable bioprocesses and next generation therapies

Bayesian optimization accelerates cell therapy process development

Antleron joins Flemish-Brabant advanced therapy delegation to Heidelberg-Mannheim ecosystem

Biodevice-CRO showcase article on BioVox

Maarten Sonnaert guides the Antleron team along its innovation-driven growth path

Antleron nominated for 2023 Flemish-Brabant Trends Gazellen

Synergy of Process Analytical Technology and QbD enables next-generation bioprocesses

Science for health: Advancing Gene Therapy - Antleron & partners show end-to-end Biodevice solution

Tommy Heck - the architect of digital twins for advanced therapy bioprocessing

Antleron presents at the Infinite-Ansys User Meeting

The antler story

Ansys Simulation World 2022 : How Antleron accelerates Smart Biomanufacturing using In Silico Tools

Additive Manufacturing – Enabling custom bioprocess solutions

Antleron will again co-organize the Life-on-Chip conference

Digital twins – An essential step towards smart ATMP processes

Collaboration with Novasign to develop novel digital tools to tackle bioprocess developm. challenges